Healthcare Finance News November 12, 2024
Jeff Lagasse

The deal is expected to add to Cencora’s capabilities in Specialty and expand its MSO business.

Drug distributor Cencora has entered into a definitive agreement to acquire Retina Consultants of America, a management services organization (MSO) of retina specialists, from Webster Equity Partners for $4.6 billion.

Cencora President and CEO Bob Mauch said in a statement that the acquisition will allow the company to broaden its relationships with community providers and place it at the forefront of retinal care.

“We intend to use our leading operational infrastructure to help RCA enhance the provider experience, drive innovative new research and create better outcomes for patients,” said Mauch, adding that Cencora will now be able to expand its MSO solutions.

RCA’s affiliated...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Trends
The CMS NHE 2023 Report: An Incomplete Picture at a Pivotal Time
Pharma At A Crossroads: Navigating Cost Pressures And Regulatory Shifts In 2025
Why Walgreens Is Reportedly Considering a Private Equity Buyer
Why 2025 Could Be A Good Reimbursement Year For CVS And Walgreens
PBM reform dropped in Congress' funding package

Share This Article